LifeStance Health Group, Inc. (LFST)
| Previous close | 7.12 |
| Open | 7.18 |
| Bid | 6.85 x 1600 |
| Ask | 6.91 x 1500 |
| Day's range | 6.82 - 7.20 |
| 52-week range | 4.74 - 9.59 |
| Volume | |
| Avg. volume | 1,256,661 |
| Market cap | 2.626B |
| Beta (5Y monthly) | 1.29 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.51 |
| Earnings date | 05 Aug 2024 - 09 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.79 |
GuruFocus.comLifeStance Health Group Inc (LFST) Q1 2024 Earnings: Misses on Revenue, Narrows Net Loss
Comprehensive Analysis of LifeStance's First Quarter Financial Performance
ZacksLifeStance Health Group (LFST) Reports Q1 Loss, Tops Revenue Estimates
LifeStance Health (LFST) delivered earnings and revenue surprises of 33.33% and 0.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswireLifeStance Reports First Quarter 2024 Results
SCOTTSDALE, Ariz., May 09, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2024. (All results compared to prior-year comparative period, unless otherwise noted)Q1 2024 Highlights and FY 2024 Outlook Revenue of $300.4 million increased 19% compared to revenue of $252.6 millionClinician base increased 15% to 6,866 clinicians, a sequen
